Delivery Order SPE2DR25D6029-SPE2DR26FXT6L
Award Date 4/29/26
Potential Completion Date 5/20/26
Potential Value $28K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $25,683.40 delivery order to Amerisourcebergen Drug Corp on April 24, 2026, for 300 milligram/3 milliliter vials of Ultomiris, with ultimate completion by May 15, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under a firm fixed-price structure with no set-aside.</p>
- <p>The Defense Logistics Agency issued a $56,503.48 delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for Ultomiris 300 mg/3 mL vials under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on April 7, 2026. No set-aside was used in the award.</p>
- <p>The Defense Logistics Agency issued a $28,251.84 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Ultomiris 1,100 mg/11 mL vials under firm fixed-price terms.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is April 15, 2026. No set-aside applies to this order.</p>
- <p>The Defense Logistics Agency issued a $28,251.84 delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for supply of Ultomiris 1,100 mg/11 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 21, 2026. Pricing is firm fixed price. No set-aside applies.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 13, 2026, for Ultomiris (pecirilumab) 300 mg/3 mL vials, with a ceiling value of $56,503.48 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 4, 2026. No set-aside was applied. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up...
- The Defense Logistics Agency awarded a delivery order valued at $28,251.84 to AmerisourceBergen Drug Corp for the supply of Ultomiris (1,100 mg/11 mL vials) under a firm fixed-price contract. This award, issued on February 4, 2026, with an ultimate completion date of February 26, 2026, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $10,273.36 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ultomiris 300 mg/3 ml vials. This competitively awarded, firm fixed price contract is scheduled for completion by January 27, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, with a ceiling value of $51,366.80 for Ultomiris 300 mg/3 ml vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price with an ultimate completion date of March 11, 2026.</p>
- The Defense Logistics Agency awarded a $52,571.70 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ultomiris 1,100 mg/11 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by October 15, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $20,146.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ultomiris (pegcetacoplan) 300 mg/3 mL vials on November 13, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The pharmaceutical...
- SPE2DR25D6029Indefinite Delivery Contract
- SPE2DR25D6029-SPE2DR26FXT6LDelivery Order
The Defense Logistics Agency issued a $28,251.81 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for Ultomiris (periphreral) 1,100 mg/11 ml vial pharmaceutical supply. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of May 20, 2026. No set-aside was used. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, competing on a full and open basis across Defense Logistics Agency medical supply vehicles.
Generated 7/28/26, 9:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 4/28/26 |